Regeneron · 14 hours ago
Senior Scientist-Bioinformatics
Regeneron is seeking a Senior Scientist-Bioinformatics to join their Molecular Profiling and Data Science Department. The role involves leading computational efforts in the Immuno-Oncology field, developing cutting-edge methods, and collaborating with biological researchers to address critical scientific questions.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Lead computational efforts in the Immuno-Oncology (IO) field by developing or applying cutting-edge methods from bulk RNA sequencing, single cell multi-omics, spatial transcriptomics and other sequencing technologies
Work in concert with oncology pre-clinical and clinical teams to design and analyze multi-omics sequencing experiments for target identification, target advancement, biomarker discovery, and clinical profiling
Prepare clear, concise presentations for collaborators and senior management
Publish and present novel findings in peer-reviewed journals and conferences
Implement and develop analysis pipelines using cutting-edge algorithms and statistically sound methodologies
Qualification
Required
Be an enthusiastic and motivated scientist who values independent research in an open and collaborative working environment
PHD 0-2 years experience
MS -4+ years experience
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase